Breaking News

Today Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Periodicals	J&J reached out to vaccine rivals to study blood clot risk, WSJ reports » 09:33 04/16/21 04/16 09:33 04/16/21 09:33 JNJ Johnson & Johnson $160.44 / +0.49 (+0.31%) , PFE Pfizer $37.61 / +0.45 (+1.21%) , MRNA Moderna $159.85 / -0.25 (-0.16%) , AZN AstraZeneca $50.84 / +0.97 (+1.95%) Johnson & Johnson… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options JNJ PFE MRNA AZN JNJ Johnson & Johnson $160.44 / +0.49 (+0.31%) 04/15/21 Evelo Biosciences appoints Luca Scavo as CFO, Julie McHugh to board of directors 04/15/21 Merck to discontinue development of MRK-7110 in COVID-19 treatment 04/14/21 EMA says 'expediting' evaluation of Johnson & Johnson COVID-19 vaccine 04/13/21 J&J pauses vaccinations in all COVID-19 vaccine clinical trials PFE Pfizer $37.61 / +0.45 (+1.21%) 06:10 Today Ideaya Biosciences announces data from ongoing darovasertib, binimetinib trial 04/13/21 Pfizer can deliver 10% more vaccine doses to U.S. by end of May, says CEO 04/13/21 White House says J&J pause will not significantly impact vaccination plan 04/13/21 Moderna up 7% to $149.10 after CDC, FDA recommend pause in J&J vaccine use MRNA Moderna $159.85 / -0.25 (-0.16%) 04/14/21 Moderna says COVID-19 vaccine seen 90% effective against all cases at six months 04/14/21 Moderna says 14 different mRNA vaccine candidates entered into trials to date 04/14/21 Moderna sees Phase 1 study of mRNA flu vaccine candidate to begin in 2021 04/14/21 Moderna updates on clinical development of HIV vaccine candidates AZN AstraZeneca $50.84 / +0.97 (+1.95%) 07:12 Today AstraZeneca reports U.S. clearance of proposed acquisition of Alexion 04/14/21 Denmark to continue vaccine rollout without AstraZeneca COVID-19 vaccine 04/14/21 AstraZeneca's Tagrisso approved in China in early lung cancer 04/12/21 AstraZeneca's DARE-19 ph.3 trial of Farxiga in COVID-19 failed primary endpoint JNJ PFE MRNA AZN JNJ Johnson & Johnson $160.44 / +0.49 (+0.31%) 04/14/21 Guggenheim Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim 04/13/21 Goldman Sachs J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs 04/13/21 Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 04/13/21 JPMorgan Vaccine pause 'incremental negative' for J&J, says JPMorgan PFE Pfizer $37.61 / +0.45 (+1.21%) 04/13/21 Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 04/13/21 JPMorgan Vaccine pause 'incremental negative' for J&J, says JPMorgan 04/09/21 Pfizer to host conference call 04/06/21 RBC Capital Pfizer transferred with a Sector Perform at RBC Capital MRNA Moderna $159.85 / -0.25 (-0.16%) 04/15/21 Piper Sandler Moderna price target raised to $234 from $208 at Piper Sandler 04/13/21 Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 04/13/21 Piper Sandler Piper reiterates $208 target on Moderna after J&J Covid vaccine pause 04/07/21 Jefferies Catalent pact with Moderna removes potential overhang, says Jefferies AZN AstraZeneca $50.84 / +0.97 (+1.95%) 04/14/21 Guggenheim Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim 04/12/21 Fly Intel: Top five analyst downgrades 04/12/21 B. Riley B. Riley calls Agenus the next Seagen, reiterates $8 target 04/12/21 Argus AstraZeneca downgraded to Hold from Buy at Argus JNJ PFE MRNA AZN JNJ Johnson & Johnson $160.44 / +0.49 (+0.31%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open PFE Pfizer $37.61 / +0.45 (+1.21%) 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer reports Q4 adjusted EPS 42c, consensus 48c 02/01/21 Notable companies reporting before tomorrow's open MRNA Moderna $159.85 / -0.25 (-0.16%) 02/25/21 Moderna reports Q4 EPS (69c), consensus (35c) 02/24/21 Notable companies reporting before tomorrow's open 02/24/21 Notable companies reporting before tomorrow's open 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) AZN AstraZeneca $50.84 / +0.97 (+1.95%) 04/07/21 EMA says benefits of AstraZeneca Covid vaccine outweigh side effects 02/11/21 AstraZeneca sees FY21 core EPS $4.75-$5.00 02/11/21 AstraZeneca reports Q4 core EPS $1.07, total revenue $7.41B 11/05/20 AstraZeneca backs view for FY20 core EPS up by a mid- to high-teens percentage 19 May JNJ PFE MRNA AZN JNJ Johnson & Johnson $160.44 / +0.49 (+0.31%) 04/15/21 CDC advisers to tentatively reconvene next week on J&J vaccine, Bloomberg says 04/15/21 Surgeon Gawande tells CNBC J&J vaccine pause should be lifted for older groups 04/15/21 J&J vaccine pause will likely last another week, FT reports 04/14/21 Top White House officials to discuss vaccine rollout with House, CNBC says PFE Pfizer $37.61 / +0.45 (+1.21%) 04/15/21 Pfizer CEO tells CNBC third vaccine dose likely needed within 12 months 04/14/21 Top White House officials to discuss vaccine rollout with House, CNBC says 04/13/21 NY replacing Tuesday's J&J vaccine appointments with Pfizer, Axios reports 04/12/21 Study shows Covid variant may evade protection from Pfizer vaccine, Reuters says MRNA Moderna $159.85 / -0.25 (-0.16%) 04/14/21 Top White House officials to discuss vaccine rollout with House, CNBC says 04/14/21 Moderna discussing COVID vaccine manufacturing with Nexus, Reuters reports 04/14/21 Moderna talking with Nexus to boost vaccine production, Reuters reports 04/06/21 U.K. to initiate Moderna vaccine rollout Wednesday, Bloomberg says AZN AstraZeneca $50.84 / +0.97 (+1.95%) 04/15/21 Surgeon Gawande tells CNBC J&J vaccine pause should be lifted for older groups 04/14/21 EU to end AstraZeneca, J&J Covid vaccine contracts in 2022, Reuters says 04/09/21 AstraZeneca slashes vaccine deliveries to EU by 49%, FT reports 04/09/21 EU evaluates J&J vaccine for blood clots, widens AstraZeneca probe, Reuters says JNJ PFE MRNA AZN JNJ Johnson & Johnson $160.44 / +0.49 (+0.31%) 04/13/21 Fly Intel: Wall Street's top stories for Tuesday 04/13/21 Fly Intel: Wall Street's top stories at midday 04/13/21 Johnson & Johnson under pressure as FDA calls for pause on COVID vaccine 04/13/21 Fly Intel: Pre-market Movers PFE Pfizer $37.61 / +0.45 (+1.21%) 04/15/21 Fly Intel: Wall Street's top stories for Thursday 04/13/21 Johnson & Johnson under pressure as FDA calls for pause on COVID vaccine 04/10/21 Opening Day: Phone maker UTime soars in public debut 04/09/21 Fly Intel: Wall Street's top stories for Friday MRNA Moderna $159.85 / -0.25 (-0.16%) 04/14/21 Fly Intel: Wall Street's top stories for Wednesday 04/14/21 Fly Intel: Wall Street's top stories at midday 04/13/21 Fly Intel: After-Hours Movers 04/13/21 Fly Intel: Wall Street's top stories for Tuesday AZN AstraZeneca $50.84 / +0.97 (+1.95%) 08:58 Today Fly Intel: Pre-market Movers 04/09/21 Fly Intel: Wall Street's top stories for Friday 04/09/21 Fly Intel: Wall Street's top stories at midday 04/07/21 Fly Intel: Wall Street's top stories for Wednesday 04/20/21 Johnson & Johnson - JNJ 04/30/21 AstraZeneca - AZN 05/04/21 Pfizer - PFE 05/07/21 Moderna - MRNA 05/06/21 FARXIGA Granted Priority Review for Chronic Kidney Disease 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 04/22/21 Pfizer Inc 04/22/21 Johnson & Johnson 04/28/21 Moderna, Inc. JNJ PFE MRNA AZN JNJ Johnson & Johnson $160.44 / +0.49 (+0.31%) 04/13/21 Unusually active option classes on open April 13th 04/01/21 Unusually active option classes on open April 1st 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th PFE Pfizer $37.61 / +0.45 (+1.21%) 04/15/21 Pfizer call volume above normal and directionally bullish 04/12/21 Unusually active option classes on open April 12th 04/09/21 Pfizer call volume above normal and directionally bullish 04/09/21 Early notable gainers among liquid option names on April 9th MRNA Moderna $159.85 / -0.25 (-0.16%) 04/14/21 Moderna call volume above normal and directionally bullish 04/13/21 Moderna call volume above normal and directionally bullish 03/17/21 Moderna call volume above normal and directionally bullish 03/01/21 Moderna call volume above normal and directionally bullish AZN AstraZeneca $50.84 / +0.97 (+1.95%) 04/01/21 AstraZeneca put volume heavy and directionally bearish 03/22/21 AstraZeneca call volume above normal and directionally bullish 03/16/21 Unusually active option classes on open March 16th 02/24/21 AstraZeneca call volume above normal and directionally bullish

Yesterday
Hot Stocks	Schrodinger holder David Shaw sells 120.4K shares of common stock » 19:00 04/15/21 04/15 19:00 04/15/21 19:00 SDGR Schrodinger $78.44 / +0.29 (+0.37%) In a regulatory filing,… In a regulatory filing, Schrodinger disclosed that David E. Shaw sold 120.4K shares of common stock on April 13th in a total transaction value of $9.29M. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options SDGR Schrodinger $78.44 / +0.29 (+0.37%) 04/12/21 Nvidia announces strategic partnership with Schrodinger 02/25/21 Schrodinger expands collaboration with Google Cloud 02/24/21 Schrodinger holder David Shaw sells 457.7K shares of common stock 01/19/21 David E Shaw reports 17.2% passive stake in Schrodinger SDGR Schrodinger $78.44 / +0.29 (+0.37%) 03/24/21 BMO Capital Schrodinger price target lowered to $104 from $110 at BMO Capital 03/15/21 Jefferies Schrodinger shares should recover on beats, discovery progress, says Jefferies 01/25/21 BMO Capital Schrodinger price target raised to $117 from $97 at BMO Capital 11/23/20 BofA BofA upgrades Schrodinger to Buy after 'major' collaboration announcement SDGR Schrodinger $78.44 / +0.29 (+0.37%) 03/04/21 Schrodinger sees FY21 revenue $124M-$142M, consensus $177.25M 03/04/21 Schrodinger reports Q4 revenue $33M, consensus $37.87M 11/12/20 Schrodinger reports Q3 EPS 5c, consensus (7c) 13 Aug SDGR Schrodinger $78.44 / +0.29 (+0.37%) 03/04/21 Fly Intel: Wall Street's top stories for Thursday 03/04/21 Fly Intel: Wall Street's top stories at midday 10/26/20 Fly Insider: Selecta, Netflix among week's notable insider trades SDGR Schrodinger $78.44 / +0.29 (+0.37%) 10/30/20 Largest borrow rate increases among liquid names
Recommendations	Moderna price target raised to $234 from $208 at Piper Sandler » 05:03 04/15/21 04/15 05:03 04/15/21 05:03 MRNA Moderna $160.10 / +10.62 (+7.10%) Piper Sandler analyst… Piper Sandler analyst Edward Tenthoff raised the firm's price target on Moderna to $234 from $208 and reiterates an Overweight rating on the shares. The stock closed Wednesday up 7% to $160.03. The company's vaccine day yesterday focused on SARS-COV-2 vaccine mRNA-1273 with Phase III COVE data out to six months showing over 90% protection against COVID-19 and over 95% protection against severe infection, Tenthoff tells investors in a research note. The analyst continue to forecast mRNA-1273 revenues of $10.85B in 2021 and $15.75B in 2022. He sees future revenues from complete vaccination in the U.S., overseas vaccinations and U.S. boosters, noting that Covid-19 is "not going away." Further, Moderna is advancing a "rich pipeline" of mRNA medicines, adds Tenthoff. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options MRNA Moderna $160.10 / +10.62 (+7.10%) 04/14/21 Moderna says COVID-19 vaccine seen 90% effective against all cases at six months 04/14/21 Moderna says 14 different mRNA vaccine candidates entered into trials to date 04/14/21 Moderna sees Phase 1 study of mRNA flu vaccine candidate to begin in 2021 04/14/21 Moderna updates on clinical development of HIV vaccine candidates MRNA Moderna $160.10 / +10.62 (+7.10%) 04/13/21 Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 04/13/21 Piper Sandler Piper reiterates $208 target on Moderna after J&J Covid vaccine pause 04/07/21 Jefferies Catalent pact with Moderna removes potential overhang, says Jefferies 03/15/21 Piper Sandler Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study MRNA Moderna $160.10 / +10.62 (+7.10%) 02/25/21 Moderna reports Q4 EPS (69c), consensus (35c) 02/24/21 Notable companies reporting before tomorrow's open 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) 19 May MRNA Moderna $160.10 / +10.62 (+7.10%) 04/14/21 Top White House officials to discuss vaccine rollout with House, CNBC says 04/14/21 Moderna discussing COVID vaccine manufacturing with Nexus, Reuters reports 04/14/21 Moderna talking with Nexus to boost vaccine production, Reuters reports 04/06/21 U.K. to initiate Moderna vaccine rollout Wednesday, Bloomberg says MRNA Moderna $160.10 / +10.62 (+7.10%) 04/14/21 Fly Intel: Wall Street's top stories for Wednesday 04/14/21 Fly Intel: Wall Street's top stories at midday 04/13/21 Fly Intel: After-Hours Movers 04/13/21 Fly Intel: Wall Street's top stories for Tuesday 05/07/21 Moderna - MRNA 04/28/21 Moderna, Inc. MRNA Moderna $160.10 / +10.62 (+7.10%) 04/14/21 Moderna call volume above normal and directionally bullish 04/13/21 Moderna call volume above normal and directionally bullish 03/17/21 Moderna call volume above normal and directionally bullish 03/01/21 Moderna call volume above normal and directionally bullish

Wednesday
Periodicals	Top White House officials to discuss vaccine rollout with House, CNBC says » 17:41 04/14/21 04/14 17:41 04/14/21 17:41 JNJ Johnson & Johnson $159.95 / +0.44 (+0.28%) , PFE Pfizer $37.16 / +0.01 (+0.03%) , BNTX BioNTech $132.52 / +3.11 (+2.40%) , MRNA Moderna $160.10 / +10.62 (+7.10%) , SPX S&P 500 / + , SPY SPDR S&P 500 ETF Trust $411.49 / -1.34 (-0.32%) The House coronavirus… The House coronavirus subcommittee will hear Thursday from three top White House health officials about the U.S.' efforts to increase vaccinations as COVID-19 cases, including those from new variants, are rising, CNBC's Kevin Breuninger reports. The hearing is set to start at 10:30 am ET and will be livestreamed, Breuninger notes. The move comes two days after dozens of states halted the administration of Johnson & Johnson's (JNJ) single dose vaccine in response to the FDA's recommendation that those shots be paused while it looks into cases of women who took the vaccine and developed a rare blood-clotting disorder, the author says. The Fly notes that the U.S. has so far approved COVID-19 vaccines from Pfizer (PFE) and BioNTech (BNTX), and Moderna (MRNA). Reference Link ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options Technical Analysis SPX PFE MRNA JNJ BNTX SPX S&P 500 / + 03/29/21 Suez Canal Authority announces refloating of Ever Given ship 03/22/21 Biden intends to nominate Lina Khan for FTC commissioner 03/08/21 ARK's Wood thinks bull market 'broadening out' to include value, strengthening 03/08/21 Tepper tells CNBC he's getting bullish on stocks with rates stabilizing PFE Pfizer $37.16 / +0.01 (+0.03%) 04/13/21 Pfizer can deliver 10% more vaccine doses to U.S. by end of May, says CEO 04/13/21 Moderna up 7% to $149.10 after CDC, FDA recommend pause in J&J vaccine use 04/12/21 AgroFresh Solutions appoints Clinton Lewis Jr. as CEO MRNA Moderna $160.10 / +10.62 (+7.10%) 04/14/21 Moderna says COVID-19 vaccine seen 90% effective against all cases at six months 04/14/21 Moderna says 14 different mRNA vaccine candidates entered into trials to date 04/14/21 Moderna sees Phase 1 study of mRNA flu vaccine candidate to begin in 2021 04/14/21 Moderna updates on clinical development of HIV vaccine candidates JNJ Johnson & Johnson $159.95 / +0.44 (+0.28%) 04/14/21 EMA says 'expediting' evaluation of Johnson & Johnson COVID-19 vaccine 04/13/21 J&J pauses vaccinations in all COVID-19 vaccine clinical trials 04/13/21 White House says J&J pause will not significantly impact vaccination plan 04/13/21 Johnson & Johnson to 'proactively delay' rollout of vaccine in Europe BNTX BioNTech $132.52 / +3.11 (+2.40%) 04/09/21 Pfizer, BioNTech seek expansion of vaccine EUA to include 12-15 year olds 04/01/21 Pfizer, BioNTech: Vaccine more than 91% effective after 6 months in study 03/31/21 BioNTech, Pfizer: 'Positive' results of COVID-19 vaccine study in adolescents JNJ PFE BNTX MRNA SPX SPY JNJ Johnson & Johnson $159.95 / +0.44 (+0.28%) 04/14/21 Guggenheim Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim 04/13/21 Goldman Sachs J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs 04/13/21 Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 04/13/21 JPMorgan Vaccine pause 'incremental negative' for J&J, says JPMorgan PFE Pfizer $37.16 / +0.01 (+0.03%) 04/09/21 Pfizer to host conference call 04/06/21 RBC Capital Pfizer transferred with a Sector Perform at RBC Capital BNTX BioNTech $132.52 / +3.11 (+2.40%) 02/23/21 B. Riley B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 01/29/21 Piper Sandler Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley MRNA Moderna $160.10 / +10.62 (+7.10%) 04/13/21 Piper Sandler Piper reiterates $208 target on Moderna after J&J Covid vaccine pause 04/07/21 Jefferies Catalent pact with Moderna removes potential overhang, says Jefferies 03/15/21 Piper Sandler Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study SPX S&P 500 / + 03/15/21 Morgan Stanley Morgan Stanley equity strategist downgrades small cap stocks 03/12/21 On The Fly: Weekly technical notes for S&P 500 01/07/21 Credit Suisse Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside 11/09/20 JPMorgan JPMorgan sees S&P 500 hitting 4,000 by early next year SPY SPDR S&P 500 ETF Trust $411.49 / -1.34 (-0.32%) SPX PFE MRNA JNJ SPX S&P 500 / + 02/23/21 S&P 500 targets FY21 EPS 3.00 to $3.20, consensus PFE Pfizer $37.16 / +0.01 (+0.03%) 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer reports Q4 adjusted EPS 42c, consensus 48c 02/01/21 Notable companies reporting before tomorrow's open MRNA Moderna $160.10 / +10.62 (+7.10%) 02/25/21 Moderna reports Q4 EPS (69c), consensus (35c) 02/24/21 Notable companies reporting before tomorrow's open 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) JNJ Johnson & Johnson $159.95 / +0.44 (+0.28%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 23 Jul 19 May SPX PFE MRNA JNJ BNTX SPX S&P 500 / + 04/14/21 Schumer to proceed with early infrastructure bill next week, Reuters says 04/06/21 California seeks to fully reopen economy June 15, L.A. Times reports 03/28/21 New Trade Representative says U.S. not ready to lift China tariffs, WSJ reports PFE Pfizer $37.16 / +0.01 (+0.03%) 04/13/21 NY replacing Tuesday's J&J vaccine appointments with Pfizer, Axios reports 04/12/21 Study shows Covid variant may evade protection from Pfizer vaccine, Reuters says 04/09/21 EU seeks contract for 1.8B COVID-19 doses with Pfizer, BioNTech, Reuters reports 04/06/21 Biden to say all U.S. adults should be vaccine-eligible by April 19, WSJ says MRNA Moderna $160.10 / +10.62 (+7.10%) 04/14/21 Moderna talking with Nexus to boost vaccine production, Reuters reports 04/06/21 U.K. to initiate Moderna vaccine rollout Wednesday, Bloomberg says JNJ Johnson & Johnson $159.95 / +0.44 (+0.28%) 04/14/21 CDC panel ends meeting w/out vote on Johnson & Johnson's vaccine, Bloomberg says 04/14/21 EU to end AstraZeneca, J&J Covid vaccine contracts in 2022, Reuters says 04/14/21 Moderna discussing COVID vaccine manufacturing with Nexus, Reuters reports 04/14/21 Italy suspends distribution of J&J COVID-19 vaccines, Reuters reports BNTX BioNTech $132.52 / +3.11 (+2.40%) 04/05/21 Pfizer working on new deal to supply COVID-19 vaccines to Israel, Reuters says PFE MRNA JNJ BNTX PFE Pfizer $37.16 / +0.01 (+0.03%) 04/10/21 Opening Day: Phone maker UTime soars in public debut 04/09/21 Fly Intel: Wall Street's top stories for Friday 04/05/21 Fly Intel: Wall Street's top stories for Monday MRNA Moderna $160.10 / +10.62 (+7.10%) 04/14/21 Fly Intel: Wall Street's top stories for Wednesday 04/14/21 Fly Intel: Wall Street's top stories at midday 04/13/21 Fly Intel: After-Hours Movers JNJ Johnson & Johnson $159.95 / +0.44 (+0.28%) 04/13/21 Fly Intel: Wall Street's top stories for Tuesday 04/13/21 Fly Intel: Wall Street's top stories at midday 04/13/21 Johnson & Johnson under pressure as FDA calls for pause on COVID vaccine 04/13/21 Fly Intel: Pre-market Movers BNTX BioNTech $132.52 / +3.11 (+2.40%) 04/01/21 Fly Intel: Wall Street's top stories for Thursday 04/01/21 Fly Intel: Wall Street's top stories at midday 04/15/21 Horizons in Oncology Virtual Conference 05/24/21 Global Healthcare Virtual Conference 2021 04/20/21 Johnson & Johnson - JNJ 05/04/21 Pfizer - PFE 05/07/21 Moderna - MRNA 05/10/21 BioNTech - BNTX 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 04/14/21 Moderna 04/14/21 Moderna, Inc. 04/22/21 Pfizer Inc 04/22/21 Johnson & Johnson 04/28/21 Moderna, Inc. SPY SPX PFE MRNA JNJ BNTX SPY SPDR S&P 500 ETF Trust $411.49 / -1.34 (-0.32%) 11/09/20 Options markets on track for record option volume SPX S&P 500 / + 04/14/21 Overnight activity included 632 trades in SPX and 31 trades in VIX 04/13/21 Overnight activity included 960 trades in SPX and 47 trades in VIX 04/12/21 Overnight activity included 1154 trades in SPX and 64 trades in VIX 04/09/21 Overnight activity included 1216 trades in SPX and 55 trades in VIX PFE Pfizer $37.16 / +0.01 (+0.03%) 04/12/21 Unusually active option classes on open April 12th 04/09/21 Pfizer call volume above normal and directionally bullish 04/09/21 Early notable gainers among liquid option names on April 9th 03/15/21 Pfizer call volume above normal and directionally bullish MRNA Moderna $160.10 / +10.62 (+7.10%) 04/14/21 Moderna call volume above normal and directionally bullish 04/13/21 Moderna call volume above normal and directionally bullish 03/17/21 Moderna call volume above normal and directionally bullish 03/01/21 Moderna call volume above normal and directionally bullish JNJ Johnson & Johnson $159.95 / +0.44 (+0.28%) 04/13/21 Unusually active option classes on open April 13th 04/01/21 Unusually active option classes on open April 1st 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th BNTX BioNTech $132.52 / +3.11 (+2.40%) 02/17/21 Largest borrow rate increases among liquid names 01/26/21 BioNTech SE put volume heavy and directionally bearish 01/19/21 Largest borrow rate increases among liquid names 11/23/20 Largest borrow rate increases among liquid names SPY SPX SPY SPDR S&P 500 ETF Trust $411.49 / -1.34 (-0.32%) 04/14/21 SPDR S&P 500 ETF Trust: Pivot points 04/13/21 SPDR S&P 500 ETF Trust: Pivot points 04/12/21 SPDR S&P 500 ETF Trust: Pivot points SPX S&P 500 / + 04/09/21 On The Fly: Weekly technical notes for S&P 500 04/01/21 On The Fly: Weekly technical notes for S&P 500 03/26/21 On The Fly: Weekly technical notes for S&P 500 03/19/21 On The Fly: Weekly technical notes for S&P 500
On The Fly	Fly Intel: Wall Street's top stories for Wednesday » 16:38 04/14/21 04/14 16:38 04/14/21 16:38 MRNA Moderna $160.10 / +10.62 (+7.10%) , GS Goldman Sachs $335.28 / +7.91 (+2.42%) , JPM JPMorgan $151.30 / -2.81 (-1.82%) , WFC Wells Fargo $42.01 / +2.25 (+5.66%) , COIN Coinbase $327.60 / -53.37 (-14.01%) , AAL American Airlines $22.37 / -0.19 (-0.84%) , JBLU JetBlue $20.83 / +0.055 (+0.26%) , TV Televisa $12.49 / +2.37 (+23.42%) , GALT Galectin Therapeutics $2.35 / +0.18 (+8.29%) , FTFT Future FinTech $4.19 / -0.79 (-15.86%) , SFIX Stitch Fix $46.86 / -2.63 (-5.31%) , BBBY Bed Bath & Beyond $24.52 / -3.375 (-12.10%) The major averages had a… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options WFC TV SFIX MRNA JPM JBLU GS GALT FTFT COIN BBBY AAL WFC Wells Fargo $42.01 / +2.25 (+5.66%) 04/14/21 Wells Fargo sees 'robust' mortgage origination volume 04/14/21 Wells Fargo sees remainder of pending branch closures this year 04/14/21 Wells Fargo still sees FY21 NII flat to down 4% 04/14/21 Wells Fargo 'making good progress' on initiatives to improve business, CEO says TV Televisa $12.49 / +2.37 (+23.42%) 04/14/21 Televisa rises 23.2% 04/14/21 Televisa rises 29.7% 04/13/21 Televisa, Univision agree to combine content, production assets SFIX Stitch Fix $46.86 / -2.63 (-5.31%) 04/13/21 Stitch Fix slips 6.3% to about $46 after CEO transition 04/13/21 Stitch Fix CEO Lake to transition to executive chairperson role 03/23/21 Stitch Fix appoints Sharon Chiarella as Chief Product Officer 03/08/21 Stitch Fix says excited about direct buy active client demand MRNA Moderna $160.10 / +10.62 (+7.10%) 04/14/21 Moderna says COVID-19 vaccine seen 90% effective against all cases at six months 04/14/21 Moderna says 14 different mRNA vaccine candidates entered into trials to date 04/14/21 Moderna sees Phase 1 study of mRNA flu vaccine candidate to begin in 2021 04/14/21 Moderna updates on clinical development of HIV vaccine candidates JPM JPMorgan $151.30 / -2.81 (-1.82%) 04/14/21 JPMorgan CEO calls for 'level playing field' with 'neobanks' 04/14/21 JPMorgan CEO says buying back stock because 'cup runneth over' 04/14/21 JPMorgan CEO 'completely open-minded' on acquisitions 04/14/21 JPMorgan CEO: Plenty of organic growth opportunities we want to invest in JBLU JetBlue $20.83 / +0.055 (+0.26%) 04/14/21 JetBlue names Carol Clements chief digital and technology officer 04/13/21 JetBlue, Qatar Airways expand strategic codeshare agreement 03/25/21 JetBlue announces launch of Paisly by JetBlue, a new travel website GS Goldman Sachs $335.28 / +7.91 (+2.42%) 04/14/21 Goldman Sachs CEO: 'Not focused' on offering crypto wallet right now 04/14/21 Goldman Sachs CEO: 'We have a plan at the moment to build a digital bank' 04/14/21 Goldman Sachs says investment banking backlog ended at record levels in Q1 04/14/21 Goldman Sachs says focused on scaling consumer digital platform GALT Galectin Therapeutics $2.35 / +0.18 (+8.29%) 04/13/21 Galectin says Phase 1 belapectin data published in JITC 04/06/21 Galectin Therapeutics launches NAVIGATEnash.com 03/31/21 Galectin expects cash to fund planned operations through March 31, 2022 03/08/21 Galectin Therapeutics announces publication on belapectin galectin-3 inhibitor FTFT Future FinTech $4.19 / -0.79 (-15.86%) 04/14/21 Future FinTech signs equity agreement to acquire cryptocurrency mining farm 04/12/21 Future FinTech enters amended agreement to acquire Nice Talent Asset Management 04/01/21 Future FinTech Group trading resumes 04/01/21 Future FinTech Group trading halted, volatility trading pause COIN Coinbase $327.60 / -53.37 (-14.01%) 04/13/21 Coinbase updates on conversion of Class B shares to Class A shares 04/06/21 Crypto Council for Innovation launches with Square,Coinbase, Fidelity as members 03/22/21 Coinbase ordered to pay $6.5M by CFTC for false, misleading reporting 12/17/20 Coinbase announces confidential submission of draft registration statement BBBY Bed Bath & Beyond $24.52 / -3.375 (-12.10%) 04/14/21 Bed Bath & Beyond says Q1 sales wont be comparable to 1Q20 04/14/21 Bed Bath & Beyond drops 7% to $25.97 after mixed Q4 results 04/14/21 Bed Bath & Beyond reports Q4 digital comp growth of +86% 04/14/21 Bed Bath & Beyond raises FY21 share repurchase plan to $325M from $300M AAL American Airlines $22.37 / -0.19 (-0.84%) 04/13/21 American Airlines sees ending Q1 with $17.3B in total available liquidity 04/05/21 CDC issues updated guidance on travel for fully vaccinated people 03/31/21 American Airlines repays $2.8B in revolving loans related to COVID 03/29/21 American Airlines now sees Q1 system capacity down 40%-45%, up from prior view MRNA GS JPM WFC COIN AAL JBLU TV GALT FTFT SFIX BBBY MRNA Moderna $160.10 / +10.62 (+7.10%) 04/15/21 Piper Sandler Moderna price target raised to $234 from $208 at Piper Sandler 04/13/21 Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 04/13/21 Piper Sandler Piper reiterates $208 target on Moderna after J&J Covid vaccine pause 04/07/21 Jefferies Catalent pact with Moderna removes potential overhang, says Jefferies GS Goldman Sachs $335.28 / +7.91 (+2.42%) 04/15/21 Barclays Goldman Sachs price target raised to $437 from $420 at Barclays 04/15/21 RBC Capital Goldman Sachs price target raised to $370 from $319 at RBC Capital 04/15/21 Piper Sandler Goldman Sachs price target raised to $385 from $365 at Piper Sandler 04/14/21 Wells Fargo Goldman Sachs price target raised to $385 from $360 at Wells Fargo JPM JPMorgan $151.30 / -2.81 (-1.82%) 04/15/21 RBC Capital JPMorgan price target raised to $160 from $150 at RBC Capital 04/15/21 Piper Sandler JPMorgan price target raised to $182 from $170 at Piper Sandler 04/14/21 Wells Fargo JPMorgan price target raised to $190 from $185 at Wells Fargo 04/09/21 Jefferies JPMorgan price target raised to $177 from $157 at Jefferies WFC Wells Fargo $42.01 / +2.25 (+5.66%) 04/15/21 Raymond James Wells Fargo price target raised to $50 from $42 at Raymond James 04/15/21 BMO Capital Wells Fargo price target raised to $43 from $40 at BMO Capital 04/15/21 Barclays Wells Fargo price target raised to $46 from $42 at Barclays 04/15/21 Baird Wells Fargo price target raised to $46 from $41 at Baird COIN Coinbase $327.60 / -53.37 (-14.01%) 04/15/21 BTIG Coinbase initiated with a Buy at BTIG 04/13/21 Fly Intel: Top five analyst initiations 04/13/21 MoffettNathanson Coinbase initiated with a Buy at MoffettNathanson 04/07/21 JMP Securities Coinbase report shows 'substantial business momentum,' says JMP Securities AAL American Airlines $22.37 / -0.19 (-0.84%) 04/15/21 Barclays American Airlines price target raised to $18 from $11 at Barclays 04/06/21 Morgan Stanley American Airlines initiated with an Underweight at Morgan Stanley 03/30/21 Fly Intel: Top five analyst upgrades 03/30/21 Jefferies Jefferies upgrades American Airlines to Hold on outperformance potential JBLU JetBlue $20.83 / +0.055 (+0.26%) 04/15/21 Barclays JetBlue price target raised to $20 from $14 at Barclays 04/14/21 Fly Intel: Top five analyst upgrades 04/14/21 JPMorgan JPMorgan double upgrades JetBlue with $25 target on positive risk/reward 04/14/21 JPMorgan JetBlue upgraded to Overweight from Underweight at JPMorgan TV Televisa $12.49 / +2.37 (+23.42%) 04/15/21 Barclays Televisa price target raised to $11 from $7.50 at Barclays 03/17/21 BBVA Televisa upgraded to Outperform from Market Perform at BBVA 12/15/20 Morgan Stanley Televisa downgraded to Equal Weight following rally at Morgan Stanley 12/15/20 Morgan Stanley Televisa downgraded to Equal Weight from Overweight at Morgan Stanley GALT Galectin Therapeutics $2.35 / +0.18 (+8.29%) FTFT Future FinTech $4.19 / -0.79 (-15.86%) SFIX Stitch Fix $46.86 / -2.63 (-5.31%) 04/05/21 Evercore ISI Stitch Fix initiated with an Outperform at Evercore ISI 03/09/21 Fly Intel: Top five analyst downgrades 03/09/21 Canaccord Stitch Fix price target lowered to $68 from $72 at Canaccord 03/09/21 KeyBanc Stitch Fix price target lowered to $75 from $95 at KeyBanc BBBY Bed Bath & Beyond $24.52 / -3.375 (-12.10%) 04/14/21 Wells Fargo Bed Bath & Beyond continues to cede market share, says Wells Fargo 02/11/21 Fly Intel: Top five analyst upgrades 02/11/21 BofA Bed Bath & Beyond upgraded to Buy after pullback at BofA 02/11/21 BofA Bed Bath & Beyond upgraded to Buy from Neutral at BofA WFC SFIX MRNA JPM JBLU GS GALT COIN BBBY AAL WFC Wells Fargo $42.01 / +2.25 (+5.66%) 04/14/21 Wells Fargo reports Q1 EPS $1.05, consensus 70c 01/15/21 Wells Fargo reports Q4 EPS 64c, consensus 60c SFIX Stitch Fix $46.86 / -2.63 (-5.31%) 03/08/21 Stitch Fix cuts FY21 revenue view to $2.02B-$2.05B from $2.05B-$2.14B 03/08/21 Stitch Fix sees Q3 revenue $505M-$515M, consensus $522.97M 03/08/21 Stitch Fix reports Q2 EPS (20c), consensus (22c) 03/08/21 Notable companies reporting after market close MRNA Moderna $160.10 / +10.62 (+7.10%) 02/25/21 Moderna reports Q4 EPS (69c), consensus (35c) 02/24/21 Notable companies reporting before tomorrow's open 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) JPM JPMorgan $151.30 / -2.81 (-1.82%) 04/14/21 JPMorgan reports Q1 EPS $4.50, consensus $3.10 01/15/21 JPMorgan reports Q4 EPS $3.79, consensus $2.62 JBLU JetBlue $20.83 / +0.055 (+0.26%) 01/28/21 JetBlue reports Q4 EPS ($1.53) consensus ($1.69) 10/27/20 JetBlue reports Q3 adj. EPS ($1.75), consensus ($2.00) GS Goldman Sachs $335.28 / +7.91 (+2.42%) 04/14/21 Goldman Sachs reports Q1 EPS $18.60, consensus $10.22 04/13/21 Fly Intel: What to watch in first round of big bank earnings reports 04/13/21 Notable companies reporting before tomorrow's open 01/19/21 Goldman Sachs reports Q4 EPS $12.08, consensus $7.47 GALT Galectin Therapeutics $2.35 / +0.18 (+8.29%) 03/31/21 Galectin Therapeutics reports 2020 EPS (41c), one est. (43c) 11/09/20 Galectin Therapeutics reports Q3 EPS (10c), one est. (14c) COIN Coinbase $327.60 / -53.37 (-14.01%) 04/06/21 Coinbase gives Q2, FY21 expenses guidance 04/06/21 Coinbase reports Q1 estimated total revenue of $1.8B BBBY Bed Bath & Beyond $24.52 / -3.375 (-12.10%) 04/14/21 Bed Bath & Beyond sees Q1 adjusted EBITDA $80M-$90M 04/14/21 Bed Bath & Beyond reports Q4 adjusted EPS 40c, consensus 31c 04/14/21 Bed Bath & Beyond sees Q1 core banner sales growth of 65%-70% 04/14/21 Bed Bath & Beyond sees FY21 revenue $8B-$8.2B, consensus $8.18B AAL American Airlines $22.37 / -0.19 (-0.84%) 04/13/21 American Airlines sees Q1 revenue down 62% from last year 01/28/21 American Airlines reports Q4 adjusted EPS ($3.86), consensus ($4.11) 01/27/21 Notable companies reporting before tomorrow's open 14 Apr 02 Dec 10 Nov 23 Jun 19 May WFC TV MRNA JPM JBLU GS FTFT COIN BBBY AAL WFC Wells Fargo $42.01 / +2.25 (+5.66%) 03/30/21 Wells Fargo intends to bring workers back to office in September, WSJ says 03/29/21 Wells Fargo offering blocks of Baidu, Farfetch, Vipshop shares, Bloomberg says 03/29/21 Wells Fargo may be shopping block of ViacomCBS shares, CNBC's Faber says 03/23/21 Wells Fargo to sell corporate trust unit for $750M, Bloomberg reports TV Televisa $12.49 / +2.37 (+23.42%) 04/13/21 Televisa to combine content, production assets with Univision, Bloomberg says MRNA Moderna $160.10 / +10.62 (+7.10%) 04/14/21 Moderna discussing COVID vaccine manufacturing with Nexus, Reuters reports 04/14/21 Moderna talking with Nexus to boost vaccine production, Reuters reports 04/06/21 U.K. to initiate Moderna vaccine rollout Wednesday, Bloomberg says 04/06/21 Biden to say all U.S. adults should be vaccine-eligible by April 19, WSJ says JPM JPMorgan $151.30 / -2.81 (-1.82%) 04/07/21 Instacart, DoorDash planning to launch own credit cards, WSJ reports 03/30/21 Dropbox, JPMorgan look to unload office space, WSJ reports 03/19/21 JPMorgan CMO Leslie Gillin leaves, Bloomberg reports 03/16/21 JPMorgan plans to have summer interns go into the office, NY Times says JBLU JetBlue $20.83 / +0.055 (+0.26%) 03/31/21 Delta Air Lines to begin selling all seats on flights starting May 1, CNBC says GS Goldman Sachs $335.28 / +7.91 (+2.42%) 04/10/21 Goldman Sachs had strong pandemic, still room to run, Barron's says 04/09/21 China's Didi Chuxing files confidentially for U.S. IPO, Bloomberg says 04/08/21 Sen. Brown seeks details of banks' ties to Archegos Capital, CNBC reports 04/08/21 Employees at Goldman's Marcus business 'quitting in droves,' BI reports FTFT Future FinTech $4.19 / -0.79 (-15.86%) 03/17/21 Future FinTech accused of fraud, called 'scam' in Reddit post COIN Coinbase $327.60 / -53.37 (-14.01%) 04/06/21 Coinbase's independent directors will have direct ties to company, WSJ reports 03/21/21 Coinbase direct listing pushed back to April, Bloomberg reports 02/19/21 'Heard on the Street' highlights PayPal, Square among crypto-exposure names 12/17/20 Coinbase filed confidentially for IPO, Bloomberg says BBBY Bed Bath & Beyond $24.52 / -3.375 (-12.10%) 02/01/21 Robinhood in talks with lenders to raise $1B in debt, Reuters reports 02/01/21 WallStreetBets tells CBS 'large amount' of stock content coming from bots AAL American Airlines $22.37 / -0.19 (-0.84%) 04/14/21 American-JetBlue partnership draws increased DOJ scrutiny, WSJ reports 03/29/21 CDC chief warns of 'impending doom' amid rise in travel, AP reports 03/18/21 Biden administration looks to ease travel restrictions in mid-May, CNBC says 03/05/21 American Air 737 MAX jet declared emergency, lands safely, Reuters says MRNA JPM JBLU GS FTFT COIN BBBY AAL MRNA Moderna $160.10 / +10.62 (+7.10%) 04/14/21 Fly Intel: Wall Street's top stories for Wednesday 04/14/21 Fly Intel: Wall Street's top stories at midday 04/13/21 Fly Intel: After-Hours Movers 04/13/21 Fly Intel: Wall Street's top stories for Tuesday JPM JPMorgan $151.30 / -2.81 (-1.82%) 03/19/21 Fly Intel: Wall Street's top stories for Friday 03/19/21 Fly Intel: Wall Street's top stories at midday JBLU JetBlue $20.83 / +0.055 (+0.26%) 04/14/21 Alphabet coverage assumption, Facebook downgrade among top calls on Wall Street 04/13/21 FedEx, Booking Holdings upgrades among today's top calls on Wall Street GS Goldman Sachs $335.28 / +7.91 (+2.42%) 04/14/21 Fly Intel: Pre-market Movers 04/01/21 Alphabet, Facebook initiations among today's top calls on Wall Street FTFT Future FinTech $4.19 / -0.79 (-15.86%) 04/01/21 Fly Intel: After-Hours Movers 04/01/21 Fly Intel: Pre-market Movers COIN Coinbase $327.60 / -53.37 (-14.01%) 04/14/21 Coinbase hits public market at $100B valuation after opening at $381 BBBY Bed Bath & Beyond $24.52 / -3.375 (-12.10%) 02/11/21 Zillow, Bed Bath & Beyond upgrades among today's top calls on Wall Street AAL American Airlines $22.37 / -0.19 (-0.84%) 04/13/21 Fly Intel: Pre-market Movers 04/05/21 Tesla upgrade, GM initiation among today's top calls on Wall Street 03/30/21 Fly Intel: Wall Street's top stories for Tuesday 13:00 Today Aerospace & Defense 04/15/21 7th Annual Virtual Retail Round-Up 04/14/21 Bed Bath & Beyond - BBBY 04/14/21 JPMorgan - JPM 04/14/21 Goldman Sachs - GS 04/14/21 Wells Fargo - WFC 04/22/21 American Airlines - AAL 04/27/21 JetBlue - JBLU 05/07/21 Moderna - MRNA 04/14/21 Moderna 04/14/21 Moderna, Inc. 04/27/21 Wells Fargo & Company 04/28/21 Moderna, Inc. 04/29/21 Goldman Sachs Group Inc. 05/13/21 JetBlue Airways Corporation 05/18/21 JPMorgan Chase & Company WFC SFIX MRNA JPM JBLU GS FTFT BBBY AAL WFC Wells Fargo $42.01 / +2.25 (+5.66%) 04/07/21 Wells Fargo 4-way spread is largest trade of the morning 03/03/21 Wells Fargo call volume above normal and directionally bullish 02/18/21 Wells Fargo call volume above normal and directionally bullish 02/16/21 Notable open interest changes for February 16th SFIX Stitch Fix $46.86 / -2.63 (-5.31%) 03/08/21 Stitch Fix options imply 27.9% move in share price post-earnings 01/05/21 Stitch Fix put volume heavy and directionally bearish 12/28/20 Stitch Fix put volume heavy and directionally bearish 12/07/20 Stitch Fix options imply 21.3% move in share price post-earnings MRNA Moderna $160.10 / +10.62 (+7.10%) 04/14/21 Moderna call volume above normal and directionally bullish 04/13/21 Moderna call volume above normal and directionally bullish 03/17/21 Moderna call volume above normal and directionally bullish 03/01/21 Moderna call volume above normal and directionally bullish JPM JPMorgan $151.30 / -2.81 (-1.82%) 03/30/21 JPMorgan call volume above normal and directionally bullish 03/19/21 Unusually active option classes on open March 19th JBLU JetBlue $20.83 / +0.055 (+0.26%) 04/14/21 Unusually active option classes on open April 14th 04/13/21 JetBlue call volume above normal and directionally bullish 02/05/21 Unusual call flow in option market yesterday 02/04/21 JetBlue call volume above normal and directionally bullish GS Goldman Sachs $335.28 / +7.91 (+2.42%) 04/09/21 Unusually active option classes on open April 9th 03/30/21 Unusually active option classes on open March 30th 03/29/21 Unusually active option classes on open March 29th 03/26/21 Unusually active option classes on open March 26th FTFT Future FinTech $4.19 / -0.79 (-15.86%) 04/12/21 Future FinTech Group options imply 20.0% move in share price post-earnings 04/01/21 Unusually active option classes on open April 1st 03/11/21 Future FinTech Group call volume above normal and directionally bullish 01/28/21 new option listings on January 28th BBBY Bed Bath & Beyond $24.52 / -3.375 (-12.10%) 04/07/21 Bed Bath & Beyond put volume heavy and directionally bearish 04/06/21 Bed Bath & Beyond put volume heavy and directionally bearish 03/15/21 Bed Bath & Beyond call volume above normal and directionally bullish 03/10/21 Unusually active option classes on open March 10th AAL American Airlines $22.37 / -0.19 (-0.84%) 04/05/21 American Airlines call volume above normal and directionally bullish 03/15/21 Early notable gainers among liquid option names on March 15th 03/12/21 American Airlines call volume above normal and directionally bullish 02/24/21 American Airlines call volume above normal and directionally bullish

Periodicals	Moderna discussing COVID vaccine manufacturing with Nexus, Reuters reports » 15:43 04/14/21 04/14 15:43 04/14/21 15:43 MRNA Moderna $158.44 / +8.96 (+5.99%) , JNJ Johnson & Johnson $159.89 / +0.38 (+0.24%) Moderna (MRNA), looking… Moderna (MRNA), looking to boost production of its COVID-19 vaccine, met with Nexus Pharmaceuticals to discuss manufacturing the shot at the company's new plant in Wisconsin, which has the capacity to process and fill 30M doses a month, Reuters' Nandita Bose reports, citing sources familiar with the matter. Senior White House and administration officials, including David Kessler, chief science officer for COVID response and Tim Manning, COVID-19 supply coordinator, have facilitated introductions and discussions between Nexus, Moderna and Johnson & Johnson (JNJ), according to two sources. Reference Link ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options MRNA JNJ MRNA Moderna $158.44 / +8.96 (+5.99%) 04/14/21 Moderna says COVID-19 vaccine seen 90% effective against all cases at six months 04/14/21 Moderna says 14 different mRNA vaccine candidates entered into trials to date 04/14/21 Moderna sees Phase 1 study of mRNA flu vaccine candidate to begin in 2021 04/14/21 Moderna updates on clinical development of HIV vaccine candidates JNJ Johnson & Johnson $159.89 / +0.38 (+0.24%) 04/14/21 EMA says 'expediting' evaluation of Johnson & Johnson COVID-19 vaccine 04/13/21 J&J pauses vaccinations in all COVID-19 vaccine clinical trials 04/13/21 White House says J&J pause will not significantly impact vaccination plan 04/13/21 Johnson & Johnson to 'proactively delay' rollout of vaccine in Europe MRNA JNJ MRNA Moderna $158.44 / +8.96 (+5.99%) 04/13/21 Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 04/13/21 Piper Sandler Piper reiterates $208 target on Moderna after J&J Covid vaccine pause 04/07/21 Jefferies Catalent pact with Moderna removes potential overhang, says Jefferies 03/15/21 Piper Sandler Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study JNJ Johnson & Johnson $159.89 / +0.38 (+0.24%) 04/14/21 Guggenheim Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim 04/13/21 Goldman Sachs J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs 04/13/21 JPMorgan Vaccine pause 'incremental negative' for J&J, says JPMorgan MRNA JNJ MRNA Moderna $158.44 / +8.96 (+5.99%) 02/25/21 Moderna reports Q4 EPS (69c), consensus (35c) 02/24/21 Notable companies reporting before tomorrow's open 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) JNJ Johnson & Johnson $159.89 / +0.38 (+0.24%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 19 May MRNA JNJ MRNA Moderna $158.44 / +8.96 (+5.99%) 04/14/21 Moderna talking with Nexus to boost vaccine production, Reuters reports 04/06/21 U.K. to initiate Moderna vaccine rollout Wednesday, Bloomberg says 04/06/21 Biden to say all U.S. adults should be vaccine-eligible by April 19, WSJ says 04/06/21 Catalent to nearly double Moderna vaccine output at Indiana plant, WSJ reports JNJ Johnson & Johnson $159.89 / +0.38 (+0.24%) 04/14/21 Italy suspends distribution of J&J COVID-19 vaccines, Reuters reports 04/14/21 J&J vaccine pause threatens public opinion on COVID-19 vaccines, FT reports 04/14/21 CDC advisory panel to meet to discuss J&J Covid vaccine, WSJ reports 04/13/21 South Africa suspends rollout of Johnson & Johnson vaccine, Bloomberg reports MRNA JNJ MRNA Moderna $158.44 / +8.96 (+5.99%) 04/14/21 Fly Intel: Wall Street's top stories at midday 04/13/21 Fly Intel: After-Hours Movers 04/13/21 Fly Intel: Wall Street's top stories for Tuesday 04/13/21 Fly Intel: Wall Street's top stories at midday JNJ Johnson & Johnson $159.89 / +0.38 (+0.24%) 04/13/21 Johnson & Johnson under pressure as FDA calls for pause on COVID vaccine 04/13/21 Fly Intel: Pre-market Movers 04/20/21 Johnson & Johnson - JNJ 05/07/21 Moderna - MRNA 04/14/21 Moderna 04/14/21 Moderna, Inc. 04/22/21 Johnson & Johnson 04/28/21 Moderna, Inc. MRNA JNJ MRNA Moderna $158.44 / +8.96 (+5.99%) 04/14/21 Moderna call volume above normal and directionally bullish 04/13/21 Moderna call volume above normal and directionally bullish 03/17/21 Moderna call volume above normal and directionally bullish 03/01/21 Moderna call volume above normal and directionally bullish JNJ Johnson & Johnson $159.89 / +0.38 (+0.24%) 04/13/21 Unusually active option classes on open April 13th 04/01/21 Unusually active option classes on open April 1st 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th
Periodicals	Moderna talking with Nexus to boost vaccine production, Reuters reports 15:39 04/14/21 04/14 15:39 04/14/21 15:39 MRNA Moderna $158.30 / +8.82 (+5.90%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options MRNA Moderna $158.30 / +8.82 (+5.90%) 04/14/21 Moderna says COVID-19 vaccine seen 90% effective against all cases at six months 04/14/21 Moderna says 14 different mRNA vaccine candidates entered into trials to date 04/14/21 Moderna sees Phase 1 study of mRNA flu vaccine candidate to begin in 2021 04/14/21 Moderna updates on clinical development of HIV vaccine candidates MRNA Moderna $158.30 / +8.82 (+5.90%) 04/13/21 Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 04/13/21 Piper Sandler Piper reiterates $208 target on Moderna after J&J Covid vaccine pause 04/07/21 Jefferies Catalent pact with Moderna removes potential overhang, says Jefferies 03/15/21 Piper Sandler Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study MRNA Moderna $158.30 / +8.82 (+5.90%) 02/25/21 Moderna reports Q4 EPS (69c), consensus (35c) 02/24/21 Notable companies reporting before tomorrow's open 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) 19 May MRNA Moderna $158.30 / +8.82 (+5.90%) 04/06/21 U.K. to initiate Moderna vaccine rollout Wednesday, Bloomberg says 04/06/21 Biden to say all U.S. adults should be vaccine-eligible by April 19, WSJ says 04/06/21 Catalent to nearly double Moderna vaccine output at Indiana plant, WSJ reports 03/26/21 White House weighs lifting IP protections for COVID-19 vaccines, CNBC says MRNA Moderna $158.30 / +8.82 (+5.90%) 04/14/21 Fly Intel: Wall Street's top stories at midday 04/13/21 Fly Intel: After-Hours Movers 04/13/21 Fly Intel: Wall Street's top stories for Tuesday 04/13/21 Fly Intel: Wall Street's top stories at midday 05/07/21 Moderna - MRNA 04/14/21 Moderna 04/14/21 Moderna, Inc. 04/28/21 Moderna, Inc. MRNA Moderna $158.30 / +8.82 (+5.90%) 04/14/21 Moderna call volume above normal and directionally bullish 04/13/21 Moderna call volume above normal and directionally bullish 03/17/21 Moderna call volume above normal and directionally bullish 03/01/21 Moderna call volume above normal and directionally bullish
On The Fly	Fly Intel: Wall Street's top stories at midday » 12:14 04/14/21 04/14 12:14 04/14/21 12:14 MRNA Moderna $156.74 / +7.26 (+4.86%) , JPM JPMorgan $153.35 / -0.76 (-0.49%) , WFC Wells Fargo $42.14 / +2.375 (+5.97%) , GS Goldman Sachs $343.02 / +15.65 (+4.78%) , COIN Coinbase $0.00 / + (+0.00%) , BBBY Bed Bath & Beyond $25.18 / -2.71 (-9.72%) , TV Televisa $12.20 / +2.08 (+20.55%) , GALT Galectin Therapeutics $2.38 / +0.21 (+9.68%) , FTFT Future FinTech $4.45 / -0.535 (-10.74%) , SFIX Stitch Fix $47.25 / -2.24 (-4.53%) The major averages are… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options WFC TV SFIX MRNA JPM GS GALT FTFT COIN BBBY WFC Wells Fargo $42.14 / +2.375 (+5.97%) 04/14/21 Wells Fargo sees 'robust' mortgage origination volume 04/14/21 Wells Fargo sees remainder of pending branch closures this year 04/14/21 Wells Fargo still sees FY21 NII flat to down 4% 04/14/21 Wells Fargo 'making good progress' on initiatives to improve business, CEO says TV Televisa $12.20 / +2.08 (+20.55%) 04/14/21 Televisa rises 23.2% 04/14/21 Televisa rises 29.7% 04/13/21 Televisa, Univision agree to combine content, production assets SFIX Stitch Fix $47.25 / -2.24 (-4.53%) 04/13/21 Stitch Fix slips 6.3% to about $46 after CEO transition 04/13/21 Stitch Fix CEO Lake to transition to executive chairperson role 03/23/21 Stitch Fix appoints Sharon Chiarella as Chief Product Officer 03/08/21 Stitch Fix says excited about direct buy active client demand MRNA Moderna $156.74 / +7.26 (+4.86%) 04/14/21 Moderna says COVID-19 vaccine seen 90% effective against all cases at six months 04/14/21 Moderna says 14 different mRNA vaccine candidates entered into trials to date 04/14/21 Moderna sees Phase 1 study of mRNA flu vaccine candidate to begin in 2021 04/14/21 Moderna updates on clinical development of HIV vaccine candidates JPM JPMorgan $153.35 / -0.76 (-0.49%) 04/14/21 JPMorgan CEO calls for 'level playing field' with 'neobanks' 04/14/21 JPMorgan CEO says buying back stock because 'cup runneth over' 04/14/21 JPMorgan CEO 'completely open-minded' on acquisitions 04/14/21 JPMorgan CEO: Plenty of organic growth opportunities we want to invest in GS Goldman Sachs $343.02 / +15.65 (+4.78%) 04/14/21 Goldman Sachs CEO: 'Not focused' on offering crypto wallet right now 04/14/21 Goldman Sachs CEO: 'We have a plan at the moment to build a digital bank' 04/14/21 Goldman Sachs says investment banking backlog ended at record levels in Q1 04/14/21 Goldman Sachs says focused on scaling consumer digital platform GALT Galectin Therapeutics $2.38 / +0.21 (+9.68%) 04/13/21 Galectin says Phase 1 belapectin data published in JITC 04/06/21 Galectin Therapeutics launches NAVIGATEnash.com 03/31/21 Galectin expects cash to fund planned operations through March 31, 2022 03/08/21 Galectin Therapeutics announces publication on belapectin galectin-3 inhibitor FTFT Future FinTech $4.45 / -0.535 (-10.74%) 04/14/21 Future FinTech signs equity agreement to acquire cryptocurrency mining farm 04/12/21 Future FinTech enters amended agreement to acquire Nice Talent Asset Management 04/01/21 Future FinTech Group trading resumes 04/01/21 Future FinTech Group trading halted, volatility trading pause COIN Coinbase $0.00 / + (+0.00%) 04/13/21 Coinbase updates on conversion of Class B shares to Class A shares 04/06/21 Crypto Council for Innovation launches with Square,Coinbase, Fidelity as members 03/22/21 Coinbase ordered to pay $6.5M by CFTC for false, misleading reporting 12/17/20 Coinbase announces confidential submission of draft registration statement BBBY Bed Bath & Beyond $25.18 / -2.71 (-9.72%) 04/14/21 Bed Bath & Beyond says Q1 sales wont be comparable to 1Q20 04/14/21 Bed Bath & Beyond drops 7% to $25.97 after mixed Q4 results 04/14/21 Bed Bath & Beyond reports Q4 digital comp growth of +86% 04/14/21 Bed Bath & Beyond raises FY21 share repurchase plan to $325M from $300M MRNA JPM WFC GS COIN BBBY TV GALT FTFT SFIX MRNA Moderna $156.74 / +7.26 (+4.86%) 04/13/21 Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 04/13/21 Piper Sandler Piper reiterates $208 target on Moderna after J&J Covid vaccine pause 04/07/21 Jefferies Catalent pact with Moderna removes potential overhang, says Jefferies 03/15/21 Piper Sandler Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study JPM JPMorgan $153.35 / -0.76 (-0.49%) 04/09/21 Jefferies JPMorgan price target raised to $177 from $157 at Jefferies 04/07/21 Barclays JPMorgan price target raised to $187 from $172 at Barclays 04/05/21 Cowen Risk to mortgage servicers rises as CFPB proposes foreclosure policy, says Cowen 04/01/21 Deutsche Bank JPMorgan price target raised to $175 from $142 at Deutsche Bank WFC Wells Fargo $42.14 / +2.375 (+5.97%) 04/09/21 Jefferies Wells Fargo price target raised to $45 from $37 at Jefferies 04/07/21 Barclays Wells Fargo price target raised to $42 from $36 at Barclays 04/01/21 Deutsche Bank Wells Fargo price target raised to $45 from $35 at Deutsche Bank GS Goldman Sachs $343.02 / +15.65 (+4.78%) 04/14/21 JMP Securities JMP reiterates Outperform rating, $400 target on Goldman after 'blockbuster' Q1 04/09/21 JMP Securities Goldman Sachs price target raised to $400 from $338 at JMP Securities 04/08/21 Citi Goldman Sachs price target raised to $390 from $370 at Citi 04/07/21 Barclays Goldman Sachs price target raised to $420 from $392 at Barclays COIN Coinbase $0.00 / + (+0.00%) 04/13/21 Fly Intel: Top five analyst initiations 04/13/21 MoffettNathanson Coinbase initiated with a Buy at MoffettNathanson 04/07/21 JMP Securities Coinbase report shows 'substantial business momentum,' says JMP Securities 03/03/21 Fly Intel: Top five analyst initiations BBBY Bed Bath & Beyond $25.18 / -2.71 (-9.72%) 02/11/21 Fly Intel: Top five analyst upgrades 02/11/21 BofA Bed Bath & Beyond upgraded to Buy after pullback at BofA 02/11/21 BofA Bed Bath & Beyond upgraded to Buy from Neutral at BofA 02/03/21 Odeon Capital Odeon sees nearly 50% upside in Bed Bath & Beyond, upgrades back to Buy TV Televisa $12.20 / +2.08 (+20.55%) 03/17/21 BBVA Televisa upgraded to Outperform from Market Perform at BBVA 12/15/20 Morgan Stanley Televisa downgraded to Equal Weight following rally at Morgan Stanley 12/15/20 Morgan Stanley Televisa downgraded to Equal Weight from Overweight at Morgan Stanley 05/12/20 Credit Suisse Televisa upgraded to Outperform from Neutral at Credit Suisse GALT Galectin Therapeutics $2.38 / +0.21 (+9.68%) FTFT Future FinTech $4.45 / -0.535 (-10.74%) SFIX Stitch Fix $47.25 / -2.24 (-4.53%) 04/05/21 Evercore ISI Stitch Fix initiated with an Outperform at Evercore ISI 03/09/21 Fly Intel: Top five analyst downgrades 03/09/21 Canaccord Stitch Fix price target lowered to $68 from $72 at Canaccord 03/09/21 KeyBanc Stitch Fix price target lowered to $75 from $95 at KeyBanc WFC SFIX MRNA JPM GS GALT COIN BBBY WFC Wells Fargo $42.14 / +2.375 (+5.97%) 04/14/21 Wells Fargo reports Q1 EPS $1.05, consensus 70c 01/15/21 Wells Fargo reports Q4 EPS 64c, consensus 60c SFIX Stitch Fix $47.25 / -2.24 (-4.53%) 03/08/21 Stitch Fix cuts FY21 revenue view to $2.02B-$2.05B from $2.05B-$2.14B 03/08/21 Stitch Fix sees Q3 revenue $505M-$515M, consensus $522.97M 03/08/21 Stitch Fix reports Q2 EPS (20c), consensus (22c) 03/08/21 Notable companies reporting after market close MRNA Moderna $156.74 / +7.26 (+4.86%) 02/25/21 Moderna reports Q4 EPS (69c), consensus (35c) 02/24/21 Notable companies reporting before tomorrow's open 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) JPM JPMorgan $153.35 / -0.76 (-0.49%) 04/14/21 JPMorgan reports Q1 EPS $4.50, consensus $3.10 04/13/21 Fly Intel: What to watch in first round of big bank earnings reports 04/13/21 Notable companies reporting before tomorrow's open 01/15/21 JPMorgan reports Q4 EPS $3.79, consensus $2.62 GS Goldman Sachs $343.02 / +15.65 (+4.78%) 04/14/21 Goldman Sachs reports Q1 EPS $18.60, consensus $10.22 01/19/21 Goldman Sachs reports Q4 EPS $12.08, consensus $7.47 GALT Galectin Therapeutics $2.38 / +0.21 (+9.68%) 03/31/21 Galectin Therapeutics reports 2020 EPS (41c), one est. (43c) 11/09/20 Galectin Therapeutics reports Q3 EPS (10c), one est. (14c) COIN Coinbase $0.00 / + (+0.00%) 04/06/21 Coinbase gives Q2, FY21 expenses guidance 04/06/21 Coinbase reports Q1 estimated total revenue of $1.8B BBBY Bed Bath & Beyond $25.18 / -2.71 (-9.72%) 04/14/21 Bed Bath & Beyond sees Q1 adjusted EBITDA $80M-$90M 04/14/21 Bed Bath & Beyond reports Q4 adjusted EPS 40c, consensus 31c 04/14/21 Bed Bath & Beyond sees Q1 core banner sales growth of 65%-70% 04/14/21 Bed Bath & Beyond sees FY21 revenue $8B-$8.2B, consensus $8.18B 14 Apr 19 May WFC TV MRNA JPM GS FTFT COIN BBBY WFC Wells Fargo $42.14 / +2.375 (+5.97%) 03/30/21 Wells Fargo intends to bring workers back to office in September, WSJ says 03/29/21 Wells Fargo offering blocks of Baidu, Farfetch, Vipshop shares, Bloomberg says 03/29/21 Wells Fargo may be shopping block of ViacomCBS shares, CNBC's Faber says 03/23/21 Wells Fargo to sell corporate trust unit for $750M, Bloomberg reports TV Televisa $12.20 / +2.08 (+20.55%) 04/13/21 Televisa to combine content, production assets with Univision, Bloomberg says MRNA Moderna $156.74 / +7.26 (+4.86%) 04/06/21 U.K. to initiate Moderna vaccine rollout Wednesday, Bloomberg says 04/06/21 Biden to say all U.S. adults should be vaccine-eligible by April 19, WSJ says 04/06/21 Catalent to nearly double Moderna vaccine output at Indiana plant, WSJ reports 03/26/21 White House weighs lifting IP protections for COVID-19 vaccines, CNBC says JPM JPMorgan $153.35 / -0.76 (-0.49%) 04/07/21 Instacart, DoorDash planning to launch own credit cards, WSJ reports 03/30/21 Dropbox, JPMorgan look to unload office space, WSJ reports 03/19/21 JPMorgan CMO Leslie Gillin leaves, Bloomberg reports 03/16/21 JPMorgan plans to have summer interns go into the office, NY Times says GS Goldman Sachs $343.02 / +15.65 (+4.78%) 04/10/21 Goldman Sachs had strong pandemic, still room to run, Barron's says 04/09/21 China's Didi Chuxing files confidentially for U.S. IPO, Bloomberg says 04/08/21 Sen. Brown seeks details of banks' ties to Archegos Capital, CNBC reports 04/08/21 Employees at Goldman's Marcus business 'quitting in droves,' BI reports FTFT Future FinTech $4.45 / -0.535 (-10.74%) 03/17/21 Future FinTech accused of fraud, called 'scam' in Reddit post COIN Coinbase $0.00 / + (+0.00%) 04/06/21 Coinbase's independent directors will have direct ties to company, WSJ reports 03/21/21 Coinbase direct listing pushed back to April, Bloomberg reports 02/19/21 'Heard on the Street' highlights PayPal, Square among crypto-exposure names 12/17/20 Coinbase filed confidentially for IPO, Bloomberg says BBBY Bed Bath & Beyond $25.18 / -2.71 (-9.72%) 02/01/21 Robinhood in talks with lenders to raise $1B in debt, Reuters reports 02/01/21 WallStreetBets tells CBS 'large amount' of stock content coming from bots WFC SFIX MRNA JPM GS FTFT COIN BBBY WFC Wells Fargo $42.14 / +2.375 (+5.97%) 02/18/21 Wells Fargo, Seagate upgrades among today's top calls on Wall Street 02/17/21 Fly Intel: Wall Street's top stories for Wednesday SFIX Stitch Fix $47.25 / -2.24 (-4.53%) 03/09/21 Fly Intel: Wall Street's top stories for Tuesday 03/09/21 Fly Intel: Wall Street's top stories at midday MRNA Moderna $156.74 / +7.26 (+4.86%) 04/13/21 Fly Intel: After-Hours Movers 04/13/21 Fly Intel: Wall Street's top stories for Tuesday 04/13/21 Fly Intel: Wall Street's top stories at midday 04/13/21 Johnson & Johnson under pressure as FDA calls for pause on COVID vaccine JPM JPMorgan $153.35 / -0.76 (-0.49%) 03/19/21 Fly Intel: Wall Street's top stories for Friday 03/19/21 Fly Intel: Wall Street's top stories at midday 01/15/21 Fly Intel: Wall Street's top stories for Friday 01/15/21 Fly Intel: Wall Street's top stories at midday GS Goldman Sachs $343.02 / +15.65 (+4.78%) 04/14/21 Fly Intel: Pre-market Movers 04/01/21 Alphabet, Facebook initiations among today's top calls on Wall Street 03/29/21 Analysts upgrade ViacomCBS, GSX Techedu as selloff in shares continues FTFT Future FinTech $4.45 / -0.535 (-10.74%) 04/01/21 Fly Intel: After-Hours Movers 04/01/21 Fly Intel: Pre-market Movers COIN Coinbase $0.00 / + (+0.00%) 04/10/21 Opening Day: Phone maker UTime soars in public debut 04/09/21 The Intersection: Crypto and Wall Street This Week BBBY Bed Bath & Beyond $25.18 / -2.71 (-9.72%) 02/11/21 Zillow, Bed Bath & Beyond upgrades among today's top calls on Wall Street 02/01/21 Square Cash App seen emerging as biggest winner from 'Robinhood drama' 01/28/21 GameStop, AMC rally after-hours as Robinhood to allow 'limited buys' 04/15/21 7th Annual Virtual Retail Round-Up 04/14/21 Bed Bath & Beyond - BBBY 04/14/21 JPMorgan - JPM 04/14/21 Goldman Sachs - GS 04/14/21 Wells Fargo - WFC 05/07/21 Moderna - MRNA 04/14/21 Moderna 04/14/21 Moderna, Inc. 04/27/21 Wells Fargo & Company 04/28/21 Moderna, Inc. 04/29/21 Goldman Sachs Group Inc. 05/18/21 JPMorgan Chase & Company WFC SFIX MRNA JPM GS FTFT BBBY WFC Wells Fargo $42.14 / +2.375 (+5.97%) 04/07/21 Wells Fargo 4-way spread is largest trade of the morning 03/03/21 Wells Fargo call volume above normal and directionally bullish 02/18/21 Wells Fargo call volume above normal and directionally bullish 02/16/21 Notable open interest changes for February 16th SFIX Stitch Fix $47.25 / -2.24 (-4.53%) 03/08/21 Stitch Fix options imply 27.9% move in share price post-earnings 01/05/21 Stitch Fix put volume heavy and directionally bearish 12/28/20 Stitch Fix put volume heavy and directionally bearish 12/07/20 Stitch Fix options imply 21.3% move in share price post-earnings MRNA Moderna $156.74 / +7.26 (+4.86%) 04/14/21 Moderna call volume above normal and directionally bullish 04/13/21 Moderna call volume above normal and directionally bullish 03/17/21 Moderna call volume above normal and directionally bullish 03/01/21 Moderna call volume above normal and directionally bullish JPM JPMorgan $153.35 / -0.76 (-0.49%) 04/09/21 Unusually active option classes on open April 9th 03/30/21 JPMorgan call volume above normal and directionally bullish 03/26/21 Unusually active option classes on open March 26th 03/19/21 Unusually active option classes on open March 19th GS Goldman Sachs $343.02 / +15.65 (+4.78%) 03/30/21 Unusually active option classes on open March 30th 03/29/21 Unusually active option classes on open March 29th FTFT Future FinTech $4.45 / -0.535 (-10.74%) 04/12/21 Future FinTech Group options imply 20.0% move in share price post-earnings 04/01/21 Unusually active option classes on open April 1st 03/11/21 Future FinTech Group call volume above normal and directionally bullish 01/28/21 new option listings on January 28th BBBY Bed Bath & Beyond $25.18 / -2.71 (-9.72%) 04/07/21 Bed Bath & Beyond put volume heavy and directionally bearish 04/06/21 Bed Bath & Beyond put volume heavy and directionally bearish 03/15/21 Bed Bath & Beyond call volume above normal and directionally bullish 03/10/21 Unusually active option classes on open March 10th
Options	Moderna call volume above normal and directionally bullish » 10:45 04/14/21 04/14 10:45 04/14/21 10:45 MRNA Moderna $155.00 / +5.52 (+3.69%) Bullish option flow… Bullish option flow detected in Moderna with 28,735 calls trading, 3x expected, and implied vol increasing almost 7 points to 66.90%. Apr-21 155 calls and Apr-21 160 calls are the most active options, with total volume in those strikes near 5,200 contracts. The Put/Call Ratio is 0.27. Earnings are expected on May 5th. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options MRNA Moderna $155.00 / +5.52 (+3.69%) 04/14/21 Moderna says COVID-19 vaccine seen 90% effective against all cases at six months 04/14/21 Moderna says 14 different mRNA vaccine candidates entered into trials to date 04/14/21 Moderna sees Phase 1 study of mRNA flu vaccine candidate to begin in 2021 04/14/21 Moderna updates on clinical development of HIV vaccine candidates MRNA Moderna $155.00 / +5.52 (+3.69%) 04/13/21 Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 04/13/21 Piper Sandler Piper reiterates $208 target on Moderna after J&J Covid vaccine pause 04/07/21 Jefferies Catalent pact with Moderna removes potential overhang, says Jefferies 03/15/21 Piper Sandler Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study MRNA Moderna $155.00 / +5.52 (+3.69%) 02/25/21 Moderna reports Q4 EPS (69c), consensus (35c) 02/24/21 Notable companies reporting before tomorrow's open 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) 19 May MRNA Moderna $155.00 / +5.52 (+3.69%) 04/06/21 U.K. to initiate Moderna vaccine rollout Wednesday, Bloomberg says 04/06/21 Biden to say all U.S. adults should be vaccine-eligible by April 19, WSJ says 04/06/21 Catalent to nearly double Moderna vaccine output at Indiana plant, WSJ reports 03/26/21 White House weighs lifting IP protections for COVID-19 vaccines, CNBC says MRNA Moderna $155.00 / +5.52 (+3.69%) 04/13/21 Fly Intel: After-Hours Movers 04/13/21 Fly Intel: Wall Street's top stories for Tuesday 04/13/21 Fly Intel: Wall Street's top stories at midday 04/13/21 Johnson & Johnson under pressure as FDA calls for pause on COVID vaccine 05/07/21 Moderna - MRNA 04/14/21 Moderna 04/14/21 Moderna, Inc. 04/28/21 Moderna, Inc. MRNA Moderna $155.00 / +5.52 (+3.69%) 04/13/21 Moderna call volume above normal and directionally bullish 03/17/21 Moderna call volume above normal and directionally bullish 03/01/21 Moderna call volume above normal and directionally bullish 02/01/21 Moderna call volume above normal and directionally bullish
Hot Stocks	Moderna says COVID-19 vaccine seen 90% effective against all cases at six months » 09:24 04/14/21 04/14 09:24 04/14/21 09:24 MRNA Moderna $149.63 / +10.34 (+7.42%) Last night, Moderna… Last night, Moderna shared an update on the Phase 3 COVE study of the Moderna COVID-19 Vaccine, mRNA-1273. "An updated review of adjudicated cases has identified over 900 cases of COVID-19 in the COVE study as of April 9th, including over 100 cases of severe COVID-19, as defined in the protocol, with a median follow-up of approximately 6 months post dose 2. Vaccine efficacy starting two weeks following the second dose and based on the updated adjudicated cases remains consistent with prior updates, including greater than 90% against all cases of COVID-19, and greater than 95% against severe cases of COVID-19. As of April 13, all placebo participants have been offered the Moderna COVID-19 Vaccine and 98% of those have received the vaccine. The COVE study is ongoing and reported results remain preliminary. Throughout the year, Moderna will be sharing updated data from the Phase 3 COVE study including efficacy against asymptomatic infection, genotyping data, additional antibody persistence data and information regarding potential correlates of protection," Moderna stated. In addition, Moderna said that in the fourth quarter of 2020, the company delivered approximately 17M doses to the U.S. government. For the first quarter of 2021, the company delivered approximately 88M doses to the U.S. government and approximately 14M doses to other customers. Through April 12, 2021, Moderna cumulatively delivered approximately 132M doses globally, including approximately 117M doses to the U.S. government and approximately 15M doses delivered from Moderna's ex-U.S. supply chain. The company said it remains on track to deliver the second 100M doses to the U.S. government by end of May 2021 followed by another 100M additional doses by end of July 2021. "The ex-U.S. supply chain was established approximately one quarter behind the U.S. supply chain and continues to ramp up," Moderna added. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options MRNA Moderna $149.63 / +10.34 (+7.42%) 04/14/21 Moderna says 14 different mRNA vaccine candidates entered into trials to date 04/14/21 Moderna sees Phase 1 study of mRNA flu vaccine candidate to begin in 2021 04/14/21 Moderna updates on clinical development of HIV vaccine candidates 04/14/21 Moderna shares plans for Phase 3 study of CMV vaccine candidate MRNA Moderna $149.63 / +10.34 (+7.42%) 04/13/21 Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 04/13/21 Piper Sandler Piper reiterates $208 target on Moderna after J&J Covid vaccine pause 04/07/21 Jefferies Catalent pact with Moderna removes potential overhang, says Jefferies 03/15/21 Piper Sandler Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study MRNA Moderna $149.63 / +10.34 (+7.42%) 02/25/21 Moderna reports Q4 EPS (69c), consensus (35c) 02/24/21 Notable companies reporting before tomorrow's open 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) 19 May MRNA Moderna $149.63 / +10.34 (+7.42%) 04/06/21 U.K. to initiate Moderna vaccine rollout Wednesday, Bloomberg says 04/06/21 Biden to say all U.S. adults should be vaccine-eligible by April 19, WSJ says 04/06/21 Catalent to nearly double Moderna vaccine output at Indiana plant, WSJ reports 03/26/21 White House weighs lifting IP protections for COVID-19 vaccines, CNBC says MRNA Moderna $149.63 / +10.34 (+7.42%) 04/13/21 Fly Intel: After-Hours Movers 04/13/21 Fly Intel: Wall Street's top stories for Tuesday 04/13/21 Fly Intel: Wall Street's top stories at midday 04/13/21 Johnson & Johnson under pressure as FDA calls for pause on COVID vaccine 05/07/21 Moderna - MRNA 04/14/21 Moderna 04/14/21 Moderna, Inc. 04/28/21 Moderna, Inc. MRNA Moderna $149.63 / +10.34 (+7.42%) 04/13/21 Moderna call volume above normal and directionally bullish 03/17/21 Moderna call volume above normal and directionally bullish 03/01/21 Moderna call volume above normal and directionally bullish 02/01/21 Moderna call volume above normal and directionally bullish

On The Fly

News and insights, exclusive to thefly.com

20:25	Notable companies reporting before tomorrow's open»
13:27	Notable companies reporting before tomorrow's open»
13:26	Notable companies reporting after market close»
09:53	Fly Intel: Top five analyst initiations»
09:53	Fly Intel: Top five analyst downgrades»

View all On The Fly Stories »

Upcoming
Events (10)

NPCE	NeuroPace - NPCE
	Texas A&M Bitcoin Virtual Conference 2021
	Annual Clinical Genetics Virtual Meeting of ACMG
FOUR ...	Technology Enabling the Restaurant Recovery
ONCR	FuboTV
WSR	Whitestone REIT
MGTA	Magenta Therapeutics
INO	FuboTV
DE	Deere
CFG	Citizens Financial - CFG

View all of today’s events »

Today’s
Syndicate (8)

AKYA	IPO
BMEA	IPO
RXRX	IPO
BALY	Secondary
MAXN	Secondary
PHX	Spot Secondary
SPNE	Spot Secondary
SYBX	Spot Secondary

View this week’s syndicate »

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial